Showing 8551-8560 of 19300 results for "".
- New GSA Publication Addresses Dementia Care in Adults with I/DDhttps://reachmd.com/news/new-gsa-publication-addresses-dementia-care-in-adults-with-idd/2457225/New GSA Publication Addresses Dementia Care in Adults with I/DD Addressing Brain Health in Adults With Intellectual Disabilities and Developmental Disabilities: A Companion to the KAER Toolkit for Primar
- Genetic Insights in Diabetes: Beyond TCF7L2 and SLC30A8https://reachmd.com/news/genetic-insights-in-diabetes-beyond-tcf7l2-and-slc30a8/2474944/Endocrinologists are increasingly challenged by evidence that gene variants such as TCF7L2 and SLC30A8 are associated with an increased risk of diabetes, which may elevate the risk of complications such as diabetic nephropathy and retinopathy
- Activation of AMP-Activated Kinase in Muscle Types: Implications for Metabolic Diseaseshttps://reachmd.com/news/activation-of-amp-activated-kinase-in-muscle-types-implications-for-metabolic-diseases/2474316/The quiet hum of cellular energy regulation might not seem like the front line in the fight against obesity and diabetes—but at its core lies AMP-activated protein kinase (AMPK), a master regulator of metabolic balance. Recent studies exploring how AMPK activation v
- The Role of PPARβ/δ in Regulating Insulin Receptor Levels: New Insights for Diabetes Managementhttps://reachmd.com/news/the-role-of-ppar-in-regulating-insulin-receptor-levels-new-insights-for-diabetes-management/2471264/Recent studies have uncovered the vital role of PPARβ/δ in regulating insulin receptor levels in skeletal muscle, offering promising avenues for managing insulin resistance and type 2 diabetes. Understanding Insulin Resistance Insulin r
- This Outdated Diabetes Drug Still Has Something to Offerhttps://reachmd.com/news/this-outdated-diabetes-drug-still-has-something-to-offer/2462707/“The exosomes were just as effective in reversing insulin resistance as the drug itself but without the same side effects,” said Olefsky. “This indicates that exosomes can ultimately link obesity-related inflammation and insulin resistance to diabetes. It also tells us
- A New Type of RNA Could Revolutionize Vaccines and Cancer Treatmentshttps://reachmd.com/news/a-new-type-of-rna-could-revolutionize-vaccines-and-cancer-treatments/2468173/A New Type of RNA Could Revolutionize Vaccines and Cancer TreatmentsAn accidental discovery turned into an unexpected success, when a team of interdisciplinary researchers created a new and improved COVID vaccine It all started in the
- High Oxygen Levels Show Limited Impact on Chemoreceptor Overactivity in Type 2 Diabeteshttps://reachmd.com/news/high-oxygen-levels-show-limited-impact-on-chemoreceptor-overactivity-in-type-2-diabetes/2470799/Could manipulating oxygen levels help manage cardiovascular and metabolic disorders? Researchers from the University of Missouri sought to answer this question by exploring the role of peripheral chemoreceptors—specialized cells near the carotid artery—in conditions like high blo
- FDA Clears First Automated Device to Deliver Insulin to People with Type 2 Diabeteshttps://reachmd.com/news/fda-clears-first-automated-device-to-deliver-insulin-to-people-with-type-2-diabetes/2467971/by Robin Foster
- Largest Study of Its Kind Finds New Genetic Risk Factors for Type 2 Diabeteshttps://reachmd.com/news/largest-study-of-its-kind-finds-new-genetic-risk-factors-for-type-2-diabetes/2462322/
- Innovative Approaches to Managing Diabetic Peripheral Neuropathyhttps://reachmd.com/news/innovative-approaches-to-managing-diabetic-peripheral-neuropathy-dpn/2474554/Diabetic peripheral neuropathy (DPN) remains a prevalent and debilitating complication of diabetes, often leading to significant morbidity. Recent innovations in therapeutic strategies are offering new avenues for clinicians to enhance patient outcomes and quality of life.<